Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.
about
Cystatin C deficiency in human atherosclerosis and aortic aneurysmsCholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesisGenomic approaches to research in pulmonary hypertensionDNA damage and repair in atherosclerosis: current insights and future perspectivesReview and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanismsDo non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.Cardiovascular aging research: the next horizons.Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets.The clonal origin and clonal evolution of epithelial tumours.Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases?Myofibroblasts: paracrine cells important in health and diseaseRole of somatic mutations in vascular disease formation.Developments in restenosis.p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells.Clonal architecture of normal and atherosclerotic aorta: implications for atherogenesis and vascular development.Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiationCoding Microsatellite Frameshift Mutations Accumulate in Atherosclerotic Carotid Artery Lesions: Evaluation of 26 Cases and Literature Review.Disruption of TGF-beta signaling in T cells accelerates atherosclerosis.Postnatal Deletion of the Type II Transforming Growth Factor-β Receptor in Smooth Muscle Cells Causes Severe Aortopathy in MiceMolecular studies on coronary artery disease-a review.Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells.Benzo[a]pyrene induces the transcription of cyclooxygenase-2 in vascular smooth muscle cells. Evidence for the involvement of extracellular signal-regulated kinase and NF-kappaB.Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors.Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells.Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis.DNA hypomethylation and methyltransferase expression in atherosclerotic lesions.Pandora's Box: mitochondrial defects in ischaemic heart disease and stroke.Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells.Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor.Expression of mRNA isoforms of latent transforming growth factor-β binding protein-1 in coronary atherosclerosis and human tissues.
P2860
Q22010733-D2CD8C09-25A2-470E-A5E8-FC24376398CDQ24294300-A34AD15D-1B92-4836-B6D4-00EC3A08A4AEQ24792044-7B9B8FA8-9336-4C89-9E9E-ED06F01C1CFDQ27001756-25D7F6DB-7E2B-4811-8132-62F68FFC683DQ28387812-B2B5000D-8588-41F0-98BB-DC273A35512BQ28387928-277667A1-1A83-48B6-8FC9-396C50B99A29Q33265315-CD4106DA-802D-4F51-80B7-F32DA48E9FFEQ33633405-42418AB6-6221-45E6-B602-6D3ED31F0384Q33643333-373B4174-BC6C-4B3A-AB58-BA44D4F51D71Q33890376-21F2641D-47CE-4706-B1E9-6AAAB6F2E497Q33947340-E86D7459-4BD8-41AF-B174-372E5517E041Q33958727-B4420330-2C33-4358-AB21-E49D69528D34Q34059841-EA73FCC5-8407-4D80-B06C-3E5AC94B858AQ35058624-E7F10585-D952-41CA-9087-9B011DCF12F9Q35745844-74C7ADFA-1D47-4792-9E62-7C27CDF55895Q35764509-62859145-8AC8-4BFD-A68C-C5566F581B4EQ35788867-143DC082-7A25-40E2-A4C9-6316A201E942Q36167056-B95F4602-C33F-4396-8315-4E29FAEC0D81Q36524547-652D5E0B-22CC-4830-8138-D1D6E8F2F33DQ36551449-42E645E9-12EE-45B2-836D-93CDE04326C1Q36946233-EBCD7A5A-9804-4FC4-8843-4D2F8ACCBA00Q37882523-F33343B6-5153-423E-B411-38897CFDB58BQ38314798-3537C1DE-A0C9-49C5-BEED-7FEEC7C80E13Q38315506-B29D5BCF-80A6-4032-959E-5036B4284B4FQ40059690-62029230-AAB3-4C04-AD45-2C867A7E65BCQ40309234-78BA6D59-6F2C-4D33-AC56-86EB7E4E244EQ43078731-B41EFF15-537D-4E5C-8A84-83334C86505DQ44040981-884E5500-AC0C-4888-BA7E-6D1980979F95Q46390109-F8CB87E2-928E-4E7D-AB30-12255E91EA8AQ46955947-935C44AB-5518-4A47-9BA9-502DDB261425Q54037308-F3E9D147-93D1-42C8-835B-535DC75209DFQ54397136-FDD57D00-F720-4018-90B8-10C923A9E0D0
P2860
Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Genomic instability in the typ ...... and restenotic vascular cells.
@en
Genomic instability in the typ ...... and restenotic vascular cells.
@nl
type
label
Genomic instability in the typ ...... and restenotic vascular cells.
@en
Genomic instability in the typ ...... and restenotic vascular cells.
@nl
prefLabel
Genomic instability in the typ ...... and restenotic vascular cells.
@en
Genomic instability in the typ ...... and restenotic vascular cells.
@nl
P2093
P2860
P356
P1476
Genomic instability in the typ ...... and restenotic vascular cells.
@en
P2093
B B Weksler
S Consigli
T A McCaffrey
T A Sanborn
P2860
P304
P356
10.1172/JCI119754
P407
P577
1997-11-01T00:00:00Z